- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
EDAP TMS SA (FOCL)
EDAP TMS SA stock price live, this page displays NASDAQ FOCL stock exchange data. View the FOCL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the EDAP TMS SA real time stock price chart below.
What Is the EDAP TMS SA Stock Price Today?
The EDAP TMS SA stock price today is 5.085.
What Is the Stock Symbol for EDAP TMS SA?
The stock symbol for EDAP TMS SA is "FOCL."
What Stock Exchange Does EDAP TMS SA Trade On?
EDAP TMS SA is listed and trades on the NASDAQ stock exchange.
Is EDAP TMS SA a Good Stock to Buy?
Determining whether EDAP TMS SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FOCL quote. (ISIN: US2683111072)
What Is the EDAP TMS SA Stock Price Today?
The EDAP TMS SA stock price today is 5.085.
What Is the Stock Symbol for EDAP TMS SA?
The stock symbol for EDAP TMS SA is "FOCL."
What Stock Exchange Does EDAP TMS SA Trade On?
EDAP TMS SA is listed and trades on the NASDAQ stock exchange.
Is EDAP TMS SA a Good Stock to Buy?
Determining whether EDAP TMS SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FOCL quote. (ISIN: US2683111072)
NASDAQ
Currency in USD
5.085
+0.105(+2.11%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.975
5.240
52 wk Range
1.210
5.240
Trading near 52-week High
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.9755.240
52 wk Range
1.2105.240
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
FOCL Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
6.875
Upside
+35.20%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
2 Buy
2 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 6.875
(+35.20% Upside)
EDAP TMS SA Earnings Call Summary for Q1/2026
- Q1 2026 revenue hit $15.42M, beating forecast by 4.4% with 25% YoY growth driven by 78% surge in HIFU segment sales.
- EPS loss of $0.2077 missed estimates of $0.19; gross margin improved to 45.7% from 42.0% YoY despite $7.4M operating loss.
- Stock surged 14.88% pre-market on revenue beat, trading at $4.17 with 87% one-year gain, though analysts flag overvaluation concerns.
- CEO Oczachowski emphasized HIFU platform expansion in U.S. and international markets as core strategic focus for growth.
- Company expects continued revenue growth but projects ongoing EPS losses; profitability not anticipated this year per analyst consensus.
Last Updated: 2026-05-13, 12:18 p/m
Read Full TranscriptEarnings
Latest Release
May 07, 2026
EPS / Forecast
-0.21 / -0.19
Revenue / Forecast
15.42M / 14.77M
Compare FOCL to Peers and Sector
Metrics to compare | FOCL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFOCLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.1x | −1.0x | −0.4x | |
PEG Ratio | 0.18 | 0.26 | 0.00 | |
Price/Book | 18.6x | 3.5x | 2.6x | |
Price / LTM Sales | 2.5x | 3.8x | 3.0x | |
Upside (Analyst Target) | 45.6% | 31.6% | 57.3% | |
Fair Value Upside | Unlock | 2.3% | 8.9% | Unlock |
EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. It also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. In addition, the company manufactures and markets lithotripter for the treatment of urinary tract stones; and provides disposables, replacement parts, and services for lithotripters; and sells spare parts and disposables, such as electrodes. Further, it markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales channels, and third-party distributors and agents. The company serves academic, public, and private hospitals, as well as clinics. The company has a strategic collaboration with Telix Pharmaceuticals Limited to develop clinical workflows combining PSMA PET imaging and Focal One Robotic HIFU for prostate cancer. EDAP TMS S.A. was incorporated in 1979 and is headquartered in Vaulx-en-Velin, France.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the EDAP (FOCL) Stock Price Today?
The EDAP stock price today is 5.085 USD.
What Stock Exchange Does EDAP Trade On?
EDAP is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for EDAP?
The stock symbol for EDAP is "FOCL."
What Is the EDAP Market Cap?
As of today, EDAP market cap is 186.660M USD.
What Is EDAP's Earnings Per Share (TTM)?
The EDAP EPS (TTM) is -0.714.
When Is the Next EDAP Earnings Date?
EDAP will release its next earnings report on Aug 26, 2026.
From a Technical Analysis Perspective, Is FOCL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has EDAP Stock Split?
EDAP has split 0 times.
How Many Employees Does EDAP Have?
EDAP has 289 employees.
What is the current trading status of EDAP (FOCL)?
As of Jun 24, 2026, EDAP (FOCL) is trading at a price of 5.085 USD, with a previous close of 4.980 USD. The stock has fluctuated within a day range of 4.975 USD to 5.240 USD, while its 52-week range spans from 1.210 USD to 5.240 USD.
What Is EDAP (FOCL) Price Target According to Analysts?
The average 12-month price target for EDAP is 6.875 USD, with a high estimate of 10 USD and a low estimate of 3 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +35.20% Upside potential.
What Is the FOCL Premarket Price?
FOCL's last pre-market stock price is 5.333 USD. The pre-market share volume is 20.000, and the stock has decreased by 0.353, or 7.090%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.